News Provided By
December 19, 2024, 10:32 GMT
Rockville, MD, United States, December 19, 2024 — On Demand Pharmaceuticals (ODP), a private company transforming pharmaceutical production, recently held a two-day meeting at North Mississippi Health Services (NMHS) in Tupelo, Mississippi. Joined by delegations from Mississippi, South Dakota, federal partners, as well as key collaborators NMHS and Germfree, the meeting spotlighted ODP’s innovative approach to addressing drug shortages and strengthening pharmaceutical supply chains. This event demonstrates ODP’s progress in forging partnerships that support its mission to make critical medicines available on demand.
The meeting provided a collaborative platform where healthcare leaders, policymakers, and industry experts examined the root causes of drug shortages and their impact on patient care. ODP shared its vision of distributed pharmaceutical production, demonstrating how its on-demand technology can help resolve supply chain disruptions and ensure medication availability at the point of care – at or near hospitals. Discussions with state representatives highlighted how ODP’s Medications as a Service model empowers health systems to produce medicines when needed, enhances transparency, and reduces price volatility, presenting a scalable solution to a national security threat.
An important aspect of the conversation was the partnership with Germfree, whose advanced cleanroom technology underpins ODP’s modular medicine producing capabilities. Tours of the “Pharmacy on Demand™ (PoD)” capabilities at NMHS showcased how the collaboration between NMHS, Germfree and ODP has resulted in a successful pilot and how this PoD ensures compliance with regulatory standards while enabling the production of sterile, high-quality medicines. Representatives from Mississippi and South Dakota expressed interest in continuing the discussion to address healthcare challenges and to respond to public health emergencies.
“This meeting highlights the importance of public-private partnerships in addressing critical healthcare challenges,” said Matt Pietras, CEO of On Demand Pharmaceuticals. “By working closely with state leaders, federal partners, and innovative organizations, we can scale our agile solution to strengthen pharmaceutical supply chains and ensure reliable access to important medicines.”
For further details, visit ODPs Website or contact us directly to learn more about our transformative technology and partnerships.
About On Demand Pharmaceuticals
On Demand Pharmaceuticals™ is a new kind of pharmaceutical company transforming how medicines are produced and delivered by enabling on-demand production—at or near the point of care to provide a high-quality, safe, and reliable supply of medicines to every community.
For media inquiries, please contact:
On Demand Pharmaceuticals
301-701-6998
Note: This press release may contain forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those expressed or implied herein.